Targeting Acinetobacter baumannii extracellular matrix to combat biofilms.
Journal name: World Journal of Pharmaceutical Research
Original article title: Acinetobacter baumannii extracellular matrix as an antibiofilm and anti-infection target
The WJPR includes peer-reviewed publications such as scientific research papers, reports, review articles, company news, thesis reports and case studies in areas of Biology, Pharmaceutical industries and Chemical technology while incorporating ancient fields of knowledge such combining Ayurveda with scientific data.
This page presents a generated summary with additional references; See source (below) for actual content.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
El Kheloui Raja, El Megdar Soufiane, Laktib Asma, Mimouni Rachida and Hamadi Fatima
Download the PDF file of the original publication
World Journal of Pharmaceutical Research:
(An ISO 9001:2015 Certified International Journal)
Full text available for: Acinetobacter baumannii extracellular matrix as an antibiofilm and anti-infection target
Source type: An International Peer Reviewed Journal for Pharmaceutical and Medical and Scientific Research
Doi: 10.20959/wjpr20226-24004
Copyright (license): WJPR: All rights reserved
Summary of article contents:
Introduction
Acinetobacter baumannii has emerged as a significant pathogenic threat in healthcare settings, largely attributed to its formidable resistance to antimicrobial agents and its capacity to thrive in harsh environments. This pathogen is notorious for forming biofilms on various surfaces, contributing to its persistence in clinical settings and posing a major challenge for treatment. The biofilm consists of bacterial cells embedded in an extracellular polymeric matrix (EPM), which serves as a protective barrier that not only enhances survival but also complicates the efficacy of traditional antibiotic treatments. This review discusses various strategies aimed at disrupting this matrix to combat A. baumannii infections.
Biofilm Formation and Its Implications
Biofilms represent a predominant growth mode of A. baumannii and consist of densely packed bacterial populations shielded by an EPM rich in extracellular DNA (eDNA), exopolysaccharides (EPS), and proteins. The process of biofilm formation progresses through several stages: adhesion to surfaces, aggregation into microcolonies, irreversible attachment, maturation, and eventual dispersal. Notably, the biofilm's EPM not only confers structural stability but also provides protection from external stressors, including antibiotics and host immune responses. The success of A. baumannii in causing infections is partly due to this biofilm formation, which correlates with increased antibiotic resistance.
The Role of Extracellular Polymeric Matrix (EPM)
The EPM serves a critical role in the biofilm's development and maintenance, representing over 90% of its dry mass. Its composition varies among bacterial species but generally consists of EPS, eDNA, and proteins. In A. baumannii, the EPM predominantly includes poly-(1-6)-N-acetylglucosamine (PNAG), biofilm-associated protein (Bap), and eDNA. This matrix not only constructs a protective environment for the bacteria but also facilitates intercellular communication, nutrient exchange, and genetic transfer, which can enhance virulence and resistance traits. The EPM acts as a diffusion barrier, complicating the penetration of antibiotics, thus heightening the challenges faced in effectively treating A. baumannii infections.
Anti-EPM Therapeutic Strategies
Given the resilience offered by the EPM, recent research has focused on developing anti-EPM strategies to disrupt biofilm formation and enhance the efficacy of antimicrobial agents. Various methods have been explored, including the use of enzymes such as DNase to cleave eDNA, Dispersin B to degrade PNAG, and agents that inhibit the expression of key biofilm components like Bap. These strategies aim to weaken the structural integrity of biofilms, thereby facilitating bacterial elimination. However, the implementation of these strategies often requires combination therapies with traditional antibiotics to ensure that the bacterial cells are effectively eradicated after the biofilm structure has been compromised.
Conclusion
The fight against A. baumannii and its associated infections necessitates a multifaceted approach aimed at disrupting biofilm formation. Targeting the EPM offers promising avenues for therapeutic intervention; however, the variability in matrix composition and structure presents challenges that must be addressed for successful treatment outcomes. Continued research in this field is essential for developing highly effective anti-biofilm strategies that can be integrated with existing antimicrobial therapies to mitigate the significant health threat posed by multidrug-resistant A. baumannii. As this area evolves, a nuanced understanding of biofilm dynamics will be crucial in shaping future therapeutic modalities.
FAQ section (important questions/answers):
What is Acinetobacter baumannii and why is it concerning?
Acinetobacter baumannii is a pathogenic bacterium responsible for severe hospital-acquired infections. Its resistance to multiple antimicrobial agents and ability to form biofilms make it a significant health threat in healthcare environments.
How does biofilm formation contribute to Acinetobacter baumannii infections?
Biofilm formation provides a protective barrier for Acinetobacter baumannii, allowing it to resist antibiotics and survive harsh environments. The extracellular polymeric matrix of the biofilm hinders treatment effectiveness, leading to persistent infections.
What components comprise the extracellular polymeric matrix of A. baumannii biofilms?
The extracellular polymeric matrix of A. baumannii biofilms primarily consists of exopolysaccharides, proteins, and extracellular DNA (eDNA). These components work together to protect and stabilize the biofilm structure.
What are some strategies to target Acinetobacter baumannii biofilms?
Strategies include using enzymes like DNase to degrade eDNA, targeting biofilm-associated proteins, and disrupting exopolysaccharides to weaken the biofilm matrix, thereby enhancing the effectiveness of antimicrobial treatments.
What role do exopolysaccharides play in A. baumannii biofilms?
Exopolysaccharides serve as structural components of the biofilm, facilitating adhesion to surfaces and protecting bacterial cells from environmental stresses and antimicrobial agents, significantly contributing to the stability of the biofilm.
How can targeting the extracellular polymeric matrix be beneficial for treatment?
Targeting the extracellular polymeric matrix can disrupt biofilm structure, enabling antibiotics to penetrate and eradicate bacterial cells. This approach aims to transition the bacteria from a resistant biofilm state to a vulnerable planktonic state.
Glossary definitions and references:
Scientific and Ayurvedic Glossary list for “Targeting Acinetobacter baumannii extracellular matrix to combat biofilms.”. This list explains important keywords that occur in this article and links it to the glossary for a better understanding of that concept in the context of Ayurveda and other topics.
1) Antibiotic (Antibacterial):
Antibacterial refers to agents that inhibit bacterial growth or kill bacteria. The presence of biofilms in A. baumannii infections complicates the efficacy of traditional antibacterial treatments, prompting the exploration of novel agents capable of disrupting biofilm integrity and enhancing treatment outcomes.
2) Surface:
Surfaces play a crucial role in biofilm formation as bacteria adhere to them to initiate growth. Various materials, such as plastics, glass, and medical devices, serve as surfaces where biofilms can thrive, underscoring the importance of surface characteristics in managing hospital-acquired infections.
3) Hand:
The hand is a common site for germ transmission and can harbor bacteria like A. baumannii, particularly in healthcare settings. Effective hand hygiene practices are critical for infection control, as contaminated hands can facilitate the spread of pathogens through direct contact or surface touching.
4) Activity:
Activity in the context of bacteria refers to metabolic and reproductive processes. A. baumannii exhibits robust activity, especially in biofilms, allowing it to survive and resist antibiotics, further complicating treatment strategies. Understanding microbial activity is essential for developing effective antimicrobial therapies.
5) Disease:
Diseases caused by A. baumannii, particularly in hospital settings, underscore the importance of infection control. Multi-drug resistant infections contribute significantly to morbidity and mortality, highlighting the need for ongoing surveillance, research, and novel treatment approaches to manage associated diseases effectively.
6) Aureus:
Staphylococcus aureus is another pathogenic bacterium often compared to A. baumannii due to their shared traits of causing hospital-acquired infections and exhibiting antibiotic resistance. Understanding the mechanisms behind their virulence can guide effective treatment strategies, particularly in tackling multidrug resistance.
7) Study (Studying):
Studies investigating A. baumannii's biofilm formation and its extracellular matrix components are crucial for identifying novel anti-biofilm strategies. Research helps elucidate bacterial behavior and resistance patterns, providing insights into combatting infections and designing more effective therapeutic interventions.
8) Life:
Life in the bacterial sense includes survival, growth, and reproduction strategies employed by pathogens like A. baumannii. Their life cycle is influenced by environmental factors, particularly in biofilms, where physiological adaptations occur to enhance resilience against adverse conditions and antimicrobial agents.
9) Glass:
Glass is a common material utilized in laboratory settings and medical devices where bacteria, including A. baumannii, can form biofilms. The physical properties of glass affect bacterial adhesion and biofilm characteristics, posing challenges in infection control and disinfection efforts in clinical environments.
10) Water:
Water acts as a medium for bacteria and biofilm development. Growth and nutrient acquisition for pathogens like A. baumannii depend on the availability of water, making it a critical environmental factor influencing biofilm formation, stability, and the overall resistance of bacteria to antimicrobials.
11) Drug:
Drugs are chemical agents used to prevent or treat diseases. The discovery and development of new drug classes to combat A. baumannii infections is vital due to increasing antibiotic resistance. Research emphasizes identifying novel compounds that can effectively target biofilm-associated bacteria.
12) Species:
Species refer to groups of organisms capable of interbreeding. A. baumannii as a species is notorious for its antibiotic resistance and adaptability in various environments, making it a significant concern in public health, particularly concerning its role in hospital-associated infections.
13) Detachment:
Detachment is the process by which bacteria release from biofilms, resulting in dispersal and potential colonization of new surfaces. Understanding detachment mechanisms in A. baumannii assists in developing interventions aimed at preventing the spread of infections in clinical settings.
14) Substance:
Substance refers to a distinct form of matter identifiable by physical or chemical properties. In the context of A. baumannii, the biofilm's extracellular polymeric substances are crucial as they create a protective environment, enhancing antibiotic resistance and complicating treatment options in healthcare.
15) Science (Scientific):
Science is the pursuit of knowledge aimed at understanding phenomena through observation and experimentation. Studying A. baumannii in scientific contexts emphasizes the need for integrated approaches to elucidate resistance mechanisms, biofilm dynamics, and the development of novel therapeutics to combat infections.
16) Channel:
Channel refers to a passageway that facilitates the movement of substances. In biofilms, channels allow nutrient flow and waste removal. Understanding the architecture of A. baumannii biofilms, including channel formation, is crucial for developing methods to disrupt these structures and combat infections.
17) Nature:
Nature encompasses the physical world, including biological organisms and ecosystems. The adaptability of A. baumannii within various natural and artificial environments showcases its resilience, enhancing the need for a comprehensive understanding of ecological interactions and implications for infection control in healthcare settings.
18) Table:
Table in scientific literature often summarizes key data points or findings in a structured format. A table summarizing anti-biofilm strategies against A. baumannii would facilitate the comparison of various approaches and their effectiveness, enabling researchers to design targeted interventions more efficiently.
19) Field:
Field refers to a branch of study or area of expertise. The field of microbiology focuses on understanding organisms like A. baumannii, aiming to unravel mechanisms of disease, resistance, and biofilm formation. Insights gained here are critical for developing effective control measures against pathogens.
20) Transformation (Transform, Transforming):
Transformed denotes a change in form or structure. In A. baumannii, transformed states may include genetic alterations that confer resistance traits, thus complicating treatment strategies. Understanding these transformed characteristics is essential for developing effective management protocols against resistant infections.
21) Transmission:
Transmission refers to the spread of pathogens from one host to another. In hospital settings, understanding the transmission dynamics of A. baumannii is crucial for implementing effective infection control measures and preventing outbreaks linked to biofilm-associated infections.
22) Accumulation (Accumulating, Accumulate):
Accumulate refers to the gradual gathering or build-up of substances. In the context of biofilms, A. baumannii may accumulate extracellular matrix components that enhance its resilience against environmental stresses and antimicrobials, showcasing the need for strategies targeting matrix composition for treatment efficacy.
23) Raja:
Raja is likely one of the authors of the study detailing A. baumannii’s biofilm characteristics and resistance mechanisms. The contributions of researchers like Raja play an essential role in advancing our understanding of microbial infections, fostering the development of novel therapeutic strategies.
24) Asma (Ashma):
Asma is likely another author contributing to the research on A. baumannii. The collaboration among researchers, including Asma, signifies the importance of interdisciplinary approaches in addressing the challenges posed by multidrug-resistant organisms in healthcare settings.
25) Beta:
Beta may refer to a form or type of protein or biochemical characteristic relevant in microbiology. Understanding beta components in the context of A. baumannii and its biofilms could facilitate insights into their structural roles and implications for antibiotic resistance and treatment strategies.
26) Food:
Food serves as a potential source of pathogens, including A. baumannii. Understanding its survival in food products raises critical public health concerns about transmission routes and zoonotic infections, necessitating effective food safety protocols and monitoring in agricultural and food processing environments.
27) Pose:
Pose refers to presenting a challenge or risk, particularly concerning A. baumannii’s resistance in healthcare. The presence of this pathogen poses significant threats to infection control, necessitating continuous research efforts to develop strategies for managing and reducing infection rates effectively.
28) Rich (Rch):
Rich typically describes environments abundant in resources, such as nutrients in biofilm matrices. A. baumannii exploits rich environments for growth and survival, underscoring the need to understand how nutrient availability influences biofilm formation and antibiotic resistance mechanisms.
29) Wall:
Wall refers to the bacterial cell wall, which provides structural integrity and protection. The characteristics of the cell wall in A. baumannii contribute to its resilience and ability to resist antibiotic treatment, making it a target for developing novel therapeutic measures.
30) Soil:
Soil is a natural habitat where various microorganisms, including A. baumannii, can exist. Studying soil environments enhances understanding of bacterial ecology and their potential reservoirs for antibiotic-resistant strains, informing prevention strategies for hospital-acquired infections and antibiotic resistance management.
Other Science Concepts:
Discover the significance of concepts within the article: ‘Targeting Acinetobacter baumannii extracellular matrix to combat biofilms.’. Further sources in the context of Science might help you critically compare this page with similair documents:
Wound infection, Antibiotic resistance, Nursing Care, Biofilm formation, Hospital Environment, Acinetobacter baumannii, Hospital acquired infection, Extracellular polymeric matrix, Extracellular DNA, Biofilm dispersion.